Because FMRP binds preferentially to ZIKV sfRNA, we tested the hypothesis that sfRNA, which accumulates to high levels during the course of infection (Figure 2A), is capable of attenuating FMRP-mediated anti-ZIKV activity. The gene discussed is FMR1; the disease is infection.